Hepatocellular carcinoma imaging systems : why they exist, how they have evolved, and how they differ
dc.contributor.author | Tang, An | |
dc.contributor.author | Cruite, Irene | |
dc.contributor.author | Mitchell, Donald G. | |
dc.contributor.author | Sirlin, Claude B. | |
dc.date.accessioned | 2023-06-20T15:28:21Z | |
dc.date.available | NO_RESTRICTION | fr |
dc.date.available | 2023-06-20T15:28:21Z | |
dc.date.issued | 2017-08-24 | |
dc.identifier.uri | http://hdl.handle.net/1866/28270 | |
dc.publisher | Springer | fr |
dc.subject | Hepatocellular carcinoma | fr |
dc.subject | Diagnosis | fr |
dc.subject | Diagnostic imaging | fr |
dc.subject | Diagnostic systems | fr |
dc.subject | Practice guidelines | fr |
dc.title | Hepatocellular carcinoma imaging systems : why they exist, how they have evolved, and how they differ | fr |
dc.type | Article | fr |
dc.contributor.affiliation | Université de Montréal. Faculté de médecine. Département de radiologie, radio-oncologie et médecine nucléaire | fr |
dc.identifier.doi | 10.1007/s00261-017-1292-3 | |
dcterms.abstract | Over the past 16 years, several scientific organizations have proposed systems that incorporate imaging for surveillance, diagnosis, staging, treatment, and monitoring of treatment response of hepatocellular carcinoma (HCC). These systems are needed to standardize the acquisition, interpretation, and reporting of liver imaging examinations; help differentiate benign from malignant observations; improve consistency between radiologists; and provide guidance for management of HCC. This review article discusses the historical evolution of HCC imaging systems. We indicate the features differentiating these systems, including target population, screening and surveillance algorithm, diagnostic imaging modalities, diagnostic scope, expertise and technical requirements, terminology, major and ancillary imaging features, staging and transplant eligibility, and assessment of treatment response. We highlight the potential benefits of unifying the systems, which we anticipate will enable sharing, pooling, and meta-analysis of data; facilitate multi-center trials; and accelerate dissemination of knowledge. | fr |
dcterms.isPartOf | urn:ISSN:2366-004X | fr |
dcterms.isPartOf | urn:ISSN:2366-0058 | fr |
dcterms.language | eng | fr |
UdeM.ReferenceFournieParDeposant | Tang, A., Cruite, I., Mitchell, D. G., & Sirlin, C. B. (2018). Hepatocellular carcinoma imaging systems: why they exist, how they have evolved, and how they differ. Abdominal radiology (New York), 43(1), 3–12. https://doi.org/10.1007/s00261-017-1292-3 | fr |
UdeM.VersionRioxx | Version acceptée / Accepted Manuscript | fr |
oaire.citationTitle | Abdominal radiology | fr |
oaire.citationVolume | 43 | fr |
oaire.citationStartPage | 3 | fr |
oaire.citationEndPage | 12 | fr |
Files in this item
This item appears in the following Collection(s)
This document disseminated on Papyrus is the exclusive property of the copyright holders and is protected by the Copyright Act (R.S.C. 1985, c. C-42). It may be used for fair dealing and non-commercial purposes, for private study or research, criticism and review as provided by law. For any other use, written authorization from the copyright holders is required.